Mesala 400 mg (Tablet (Delayed Release))
Unit Price: ৳ 7.00 (5 x 10: ৳ 350.00)
Strip Price: ৳ 70.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Mesalazine 5 aminosalicylic acid |
| Company | Nipro jmi pharma ltd |
Title
- Mesala
Categories
- Medicine
- Medical Supplies
- Gastrointestinal Health
Description
- Mesala is indicated for the treatment of mild to moderately active Ulcerative Colitis & Crohn’s Disease, maintenance of remission of Ulcerative Colitis, and maintenance of remission of Crohn’s disease.
Color Options
- White
Function
- Treatment of Ulcerative Colitis & Crohn’s Disease
- Maintenance of Remission
Usability Features
- Oral Administration
- Delayed-Release Granules
- Symptomatic and Supportive Treatment for Suspected Overdose
Materials
- Aminosalicylates
Technical Specifications
- Topical rather than systemic action
- Blocks cyclooxygenase and inhibits prostaglandin production
Design Elements
- Delayed-Release Granules
- Acid-Resistant Coating
Dosage and Administration
- Individual dosage up to 4 gm mesalazine once daily or divided into 2-4 doses for active disease in adults
- Recommended dosage of 2 gm mesalazine once daily for maintenance treatment in adults
Pediatric Dosage and Administration
- To be determined individually based on age and weight
- Maximum dose of 75 mg/kg/day in divided doses for active disease in children
- Maximum dose of 2 g/day for maintenance treatment in children
Dosage Forms
- Granules
Age Restrictions
- Not recommended for children below 6 years of age
Dosage Administration Method
- Empty granule contents onto the tongue and wash down with water or orange juice
- Or consume with yogurt
Contraindications
- Hypersensitivity to salicylates or any other component of the formulation
Side Effects
- Headache
- Nausea
- Dizziness
- Asthenia
- Dyspepsia
- Vomiting
- Pruritus
Interaction
- Concurrent use of nephrotoxic agents may increase the risk of renal reactions
Pregnancy & Lactation
- Caution advised during pregnancy and nursing
Precautions
- Prolonged gastric retention in patients with pyloric stenosis
- Monitor renal function in patients with known renal dysfunction or history of renal disease
- Exercise caution in patients with liver impairment
Special Population Uses
- Closely monitor blood cell counts in patients who are 65 years or older during therapy
- Evaluate renal function prior to initiation in elderly patients
- Not established for pediatric use
Overdose Effects
- No specific antidote available
- Symptomatic and supportive treatment recommended
- Consider pH dependent delayed-release feature
Therapeutic Class
- Aminosalicylates
Storage Conditions
- Store below 30°C
- Protect from light and moisture
- Keep out of reach of children